KFMB - SAN FRANCISCO — VaxGen Inc.’s troubled $877.5 million federal contract to produce a new anthrax vaccine hit another snag Friday that delayed delivery of the shots a third time and jeopardized the struggling company’s future. The Food and Drug …



WAOW - SAN FRANCISCO (AP) — VaxGen Inc.’s troubled $877.5 million federal contract to produce a new anthrax vaccine hit another snag Friday that delayed delivery of the shots a third time and jeopardized the struggling company’s future. The Food and Drug …